HEQCX Performance — Monteagle Opportunity Equity Fund, Institutional Class
Data updated: 2026-07-29
HEQCX returned +9.20% year to date and +22.34% over one year to May 2026. Annualised returns are +14.80% over 3 years and +8.20% over 5 years. Against its US Mid-Cap Growth category average the fund came out behind over three years but ahead over one: $100 invested three years ago grew to $151, against $157 for the category, and to $122 over one year, against $119. Volatility over the past three years was 14.97% a year. In the 12 months to May 2026 the fund took in a net $1.5M, and assets reached $17.41M.
HEQCX Growth of $100
What $100 invested in Monteagle Opportunity Equity Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Mid-Cap Growth category average over the same months.
| Period | HEQCX | Category average |
|---|---|---|
| 1 year (Jun 2025 – May 2026) | $122 | $119 |
| 3 years (Jun 2023 – May 2026) | $151 | $157 |
| 5 years (Jun 2021 – May 2026) | $148 | $129 |
| Since data start (Mar 2020 – May 2026) | $218 | $198 |
HEQCX Trailing Returns
Total returns to May 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +9.20% |
| 1 year | +22.34% |
| 3 years (annualised) | +14.80% |
| 5 years (annualised) | +8.20% |
HEQCX Annual Returns
Calendar-year total returns of Monteagle Opportunity Equity Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–May) | +9.20% |
| 2025 | +10.34% |
| 2024 | +8.16% |
| 2023 | +13.91% |
| 2022 | −4.81% |
| 2021 | +20.38% |
| 2020 (Mar–Dec) | +28.33% |
HEQCX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +5.4% | +2.1% | −4.5% | +6.1% | +0.2% | — | — | — | — | — | — | — |
| 2025 | +3.3% | −2.1% | −3.9% | −2.5% | +3.9% | +3.2% | +1.8% | +4.9% | 0.0% | −1.7% | +2.1% | +1.3% |
| 2024 | −1.3% | +2.9% | +3.7% | −5.5% | +3.7% | −2.4% | +7.6% | +0.2% | +1.4% | −1.9% | +7.9% | −7.1% |
| 2023 | +7.1% | −2.4% | −2.1% | +0.3% | −4.4% | +7.2% | +4.6% | −2.8% | −4.5% | −5.1% | +7.7% | +9.1% |
| 2022 | −2.6% | −0.2% | +0.9% | −5.3% | +3.1% | −7.4% | +7.5% | −2.6% | −8.8% | +10.8% | +5.9% | −4.2% |
| 2021 | +0.7% | +6.2% | +3.4% | +3.9% | −0.1% | −0.7% | +1.2% | +1.0% | −4.8% | +4.4% | −2.6% | +6.8% |
| 2020 | — | — | −15.4% | +12.5% | +5.3% | +1.6% | +4.6% | +3.9% | −2.5% | 0.0% | +13.1% | +5.1% |
HEQCX Risk
Risk measures from monthly returns over Jun 2023 – May 2026.
- 3-year volatility (annualised): 14.97%
- 3-year Sharpe ratio: 0.69 (vs 4.5% risk-free rate)
- Best month: +9.13% (Dec 2023)
- Worst month: −7.13% (Dec 2024)
HEQCX Fund Flows
Monthly money in and out of Monteagle Opportunity Equity Fund, from SEC Form N-PORT.
- 12-month net flow: $1.5M
- 12-month gross sales (incl. reinvestments): $4.7M
- Sales ÷ redemptions: 1.45×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2026 | $44K | $431K | −$387K |
| Apr 2026 | $1.3M | $75K | $1.2M |
| Mar 2026 | $47K | $342K | −$295K |
| Feb 2026 | $20K | $435K | −$414K |
| Jan 2026 | $46K | $239K | −$193K |
| Dec 2025 | $1.6M | $281K | $1.3M |
| Nov 2025 | $25K | $504K | −$479K |
| Oct 2025 | $1.4M | $656K | $768K |
| Sep 2025 | $26K | $41K | −$14K |
| Aug 2025 | $57K | $23K | $35K |
| Jul 2025 | $56K | $88K | −$31K |
| Jun 2025 | $73K | $139K | −$65K |
HEQCX Assets Under Management
Net assets of Monteagle Opportunity Equity Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-05-31 | $17.41M |
| 2026-02-28 | $16.66M |
| 2025-11-30 | $16.05M |
| 2025-08-31 | $15.77M |
| 2025-05-31 | $14.42M |
| 2025-02-28 | $16.04M |
| 2024-11-30 | $17.50M |
| 2024-08-31 | $16.57M |
| 2024-05-31 | $16.62M |
| 2024-02-29 | $16.50M |
| 2023-11-30 | $15.85M |
| 2023-08-31 | $25.39M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.